13F Filings History of Reynders McVeigh Capital Management, LLC

Latest 13F report
Q3 2025 - 17 Nov 2025
Value $
$2,132,653,000
Signature - Title
Kevin Fairweather - Controller
Location
Boston, MA
Summary
This page shows a list of all the recent 13F filings made by Reynders McVeigh Capital Management, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Reynders McVeigh Capital Management, LLC reported 201 stock holdings with total value $2,132,653,000 as of Q3 2025. Top holdings included NVDA, AAPL, MSFT, MA, and ROK.

Notify me when Reynders McVeigh Capital Management, LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2025 201 $2,132,653,000 +$66,475,543 -$41,937,229 +$24,538,314 NVDA, AAPL, MSFT, MA, ROK 13F-HR 14 Nov 2025, 19:22
Q2 2025 195 $2,003,162,000 +$84,434,623 -$81,826,819 +$2,607,804 NVDA, AAPL, MSFT, MA, ROK 13F-HR 04 Sep 2025, 16:00
Q1 2025 193 $1,791,141,000 +$53,033,316 -$77,375,415 -$24,342,099 NVDA, AAPL, MA, MSFT, TMUS 13F-HR 12 May 2025, 13:41
Q4 2024 202 $1,899,855,000 +$69,355,317 -$61,361,745 +$7,993,572 NVDA, AAPL, MSFT, MA, CARR 13F-HR 13 Feb 2025, 14:55
Q3 2024 203 $1,887,260,000 +$60,345,401 -$40,270,725 +$20,074,676 NVDA, AAPL, MSFT, CARR, MA 13F-HR 14 Nov 2024, 16:11
Q2 2024 198 $1,760,390,000 +$240,255,589 -$117,609,761 +$122,645,828 NVDA, AAPL, MSFT, MA, CARR 13F-HR 13 Aug 2024, 13:43
Q1 2024 199 $1,736,743,000 +$67,740,026 -$51,863,826 +$15,876,200 NVDA, AAPL, MSFT, MA, NVO 13F-HR 07 May 2024, 16:23
Q4 2023 195 $1,578,996,000 +$64,928,882 -$81,103,640 -$16,174,758 AAPL, NVDA, MSFT, MA, ROK 13F-HR 07 Feb 2024, 16:37
Q3 2023 210 $1,455,229,000 +$60,862,429 -$48,281,097 +$12,581,332 AAPL, NVDA, MSFT, MA, ROK 13F-HR 09 Nov 2023, 11:31
Q2 2023 205 $1,525,701,000 +$31,929,767 -$52,755,035 -$20,825,268 AAPL, NVDA, ROK, MSFT, MA 13F-HR 09 Aug 2023, 10:59
Q1 2023 203 $1,453,122,000 +$23,157,557 -$54,901,142 -$31,743,585 AAPL, ROK, ADI, NVDA, MA 13F-HR 03 May 2023, 11:45
Q4 2022 210 $1,361,471,000 +$24,397,444 -$54,516,564 -$30,119,120 AAPL, DHR, MA, ROK, ADI 13F-HR 10 Feb 2023, 14:22
Q3 2022 207 $1,287,384,000 +$102,435,546 -$20,863,443 +$81,572,103 AAPL, DHR, MA, MSFT, ROK 13F-HR 08 Nov 2022, 13:14
Q2 2022 218 $1,333,064,264 +$51,170,231 -$26,626,884 +$24,543,347 AAPL, DHR, MA, MSFT, ADI 13F-HR 05 Aug 2022, 14:07
Q1 2022 229 $1,635,675,324 +$55,536,104 -$22,465,182 +$33,070,922 AAPL, DHR, NVDA, MSFT, MA 13F-HR 11 May 2022, 16:21
Q4 2021 239 $1,762,454,382 +$30,135,424 -$31,764,202 -$1,628,778 AAPL, DHR, NVDA, ROK, MSFT 13F-HR 11 Feb 2022, 14:34
Q3 2021 222 $1,633,427,000 +$72,321,758 -$24,984,310 +$47,337,448 AAPL, DHR, PYPL, ROK, MA 13F-HR 15 Nov 2021, 17:27
Q2 2021 232 $1,632,184,000 +$42,295,734 -$34,402,772 +$7,892,962 AAPL, PYPL, DHR, MA, ROK 13F-HR 12 Aug 2021, 14:23
Q1 2021 229 $1,500,347,000 +$79,392,760 -$57,277,526 +$22,115,234 AAPL, PYPL, MA, DHR, DIS 13F-HR 07 May 2021, 12:16
Q4 2020 222 $1,463,603,000 +$43,757,076 -$38,489,110 +$5,267,966 AAPL, PYPL, MA, DHR, DIS 13F-HR 10 Feb 2021, 15:41
Q3 2020 224 $1,296,623,000 +$128,585,601 -$26,553,696 +$102,031,905 AAPL, MA, DHR, PYPL, NKE 13F-HR 28 Oct 2020, 13:28
Q2 2020 209 $1,142,951,000 +$83,825,148 -$21,427,974 +$62,397,174 AAPL, MA, PYPL, DHR, ROK 13F-HR 14 Aug 2020, 15:06
Q1 2020 193 $878,143,000 +$39,670,925 -$35,581,296 +$4,089,629 AAPL, MA, DHR, TDOC, ABT 13F-HR 13 May 2020, 13:26
Q4 2019 228 $1,037,510,000 +$44,560,099 -$17,928,278 +$26,631,821 AAPL, MA, DIS, DHR, ROK 13F-HR 14 Feb 2020, 13:16
Q3 2019 224 $936,576,000 +$27,067,373 -$17,190,450 +$9,876,923 MA, AAPL, DHR, DIS, SYK 13F-HR 08 Nov 2019, 14:56
Q2 2019 213 $932,354,000 +$19,451,051 -$30,742,575 -$11,291,524 MA, AAPL, DIS, DHR, PYPL 13F-HR 06 Aug 2019, 16:21
Q1 2019 210 $904,263,000 +$46,508,711 -$14,168,900 +$32,339,811 MA, AAPL, DHR, PYPL, NVS 13F-HR 10 May 2019, 14:26
Q4 2018 206 $753,901,000 +$34,304,829 -$18,124,348 +$16,180,481 MA, AAPL, JNJ, DIS, NVS 13F-HR 14 Feb 2019, 15:21
Q3 2018 201 $851,444,000 +$19,994,141 -$27,474,021 -$7,479,880 AAPL, MA, JNJ, ILMN, DIS Restatement 26 Nov 2018, 10:37
Q2 2018 203 $784,023,000 +$38,620,008 -$58,811,368 -$20,191,360 MA, AAPL, JNJ, DIS, GOOGL 13F-HR 09 Aug 2018, 15:05
Q1 2018 197 $790,771,000 +$59,771,956 -$21,018,889 +$38,753,067 MA, AAPL, JNJ, XYL, NVS Restatement 26 Jul 2018, 15:37
Q4 2017 202 $762,978,000 +$15,083,183 -$59,084,730 -$44,001,547 AAPL, PG, MA, JNJ, ROK 13F-HR 06 Feb 2018, 16:18
Q3 2017 212 $766,907,000 +$27,624,367 -$31,518,102 -$3,893,735 PG, AAPL, MA, ROK, JNJ 13F-HR 09 Nov 2017, 16:01
Q2 2017 222 $747,135,000 +$27,295,777 -$36,441,442 -$9,145,665 PG, AAPL, JNJ, CVS, ROK 13F-HR 14 Aug 2017, 16:23
Q1 2017 223 $728,016,000 +$40,121,214 -$50,484,971 -$10,363,757 PG, AAPL, JNJ, CVS, ROK 13F-HR 27 Apr 2017, 13:02
Q4 2016 225 $704,141,000 +$36,989,518 -$18,241,571 +$18,747,947 PG, CVS, AAPL, JNJ, ROK 13F-HR 14 Feb 2017, 10:04
Q3 2016 211 $686,491,000 +$45,030,327 -$33,753,881 +$11,276,446 PG, CVS, AAPL, JNJ, NVS 13F-HR 07 Nov 2016, 14:11
Q2 2016 218 $688,876,000 +$56,995,788 -$22,725,487 +$34,270,301 CVS, PG, JNJ, NVS, ROK 13F-HR 03 Aug 2016, 17:40
Q1 2016 220 $675,652,000 +$105,401,905 -$17,452,823 +$87,949,082 CVS, PG, JNJ, MA, AAPL 13F-HR 13 May 2016, 14:44
Q4 2015 201 $610,117,000 +$76,469,971 -$25,918,158 +$50,551,813 CVS, PG, MA, NVS, ADP 13F-HR 16 Feb 2016, 13:55
Q3 2015 201 $574,124,000 +$48,684,029 -$18,924,716 +$29,759,313 CVS, PG, NVS, MA, ADP 13F-HR 10 Nov 2015, 14:30
Q2 2015 204 $612,293,000 +$62,458,797 -$7,297,707 +$55,161,090 CVS, PG, NVS, JCI, MA 13F-HR 12 Aug 2015, 15:31
Q1 2015 173 $582,017,000 +$59,354,528 -$33,534,760 +$25,819,768 CVS, PG, NVS, JCI, ADP 13F-HR 08 May 2015, 17:30
Q4 2014 170 $569,935,000 +$32,826,123 -$20,511,359 +$12,314,764 CVS, PG, NVS, JCI, JNJ 13F-HR 06 Feb 2015, 20:27
Q3 2014 163 $526,073,000 +$101,580,458 -$7,642,292 +$93,938,166 CVS, PG, NVS, JNJ, ADP Restatement 07 Nov 2014, 09:36
Q2 2014 163 $439,300,000 +$38,625,352 -$19,015,002 +$19,610,350 CVS, PG, JCI, JNJ, NVS 13F-HR 11 Aug 2014, 13:11
Q1 2014 161 $422,329,000 +$29,087,648 -$10,465,750 +$18,621,898 PG, CVS, JCI, JNJ, NVS 13F-HR 12 May 2014, 09:02
Q4 2013 157 $404,150,000 $0 PG, CVS, JCI, ADP, EMR 13F-HR 06 Feb 2014, 20:08